Mar 28, 2011
Planning Group members Sandra M. Swain, MD, a medical oncologist, and Richard M. Steingart, MD, a cardiologist, collaborate to identify topic areas in each module and to identify experts in cardiology and oncology to present the case discussion.
“This new series addresses some of the difficult cardiac issues that must be managed in our patients,” said Dr. Swain. “Physicians from both subspecialties need to know how to deal with issues such as cardiac toxicities arising from cancer treatments, and late effects and survivorship issues experienced by patients treated for childhood cancers.”
First module available
The first module in the series is available now on ASCO University (university. asco.org/cardiac). The case topic, presented by Charles E. Geyer, MD, and Michael S. Ewer, MD, deals with toxicities associated with trastuzumab and anthracyclines. A second module will be available in May and will focus on hypertension and vascular endothelial growth factor (VEGF) signaling pathway (VSP) inhibitors.
ASCO Announces 2011-2012 Leadership Development Program Participants
Anne C. Chiang, MD, PhD
Connecticut Oncology and Hematology, LLP
2005 YIA* recipient;
2007 CDA** recipient
Cathy Eng, MD
University of Texas M. D. Anderson Cancer Center
Ralph J. Hauke, MD
Nebraska Cancer Specialists
Reshma Jagsi, MD
University of Michigan
Tari A. King, MD
Memorial Sloan-Kettering Cancer Center
Natasha B. Leighl, MD
Princess Margaret Hospital
2001 YIA recipient;
2002 CDA recipient
Bruno C. Medeiros, MD
Stanford Cancer Center
2007 YIA recipient
Wells A. Messersmith, MD
University of Colorado
2004 YIA recipient
Ann H. Partridge, MD
Dana-Farber Cancer Institute
2001 YIA recipient;
2003 CDA recipient;
2010 ICCG recipient***
Blase N. Polite, MD, MPH
University of Chicago
2008 CDA recipient
Karen L. Reckamp, MD
City of Hope
2001 YIA recipient
Lecia V. Sequist, MD, MPH
Massachusetts General Hospital
*Young Investigator Award
**Career Development Award
***Improving Cancer Care Grant
Looking to host a local Best of ASCO® meeting?
ASCO-endorsed Best of ASCO Meetings bring the highlights of the Annual Meeting to you. Each year, a panel of ASCO experts selects Annual Meeting abstracts and licenses the program as a Best of ASCO meeting to oncology organizations in the United States and around the world. For more information, send an e-mail to boalicensing@asco.org.
2011 Breast Cancer SymposiumCall for Abstracts
- Submission deadline: May 10, 2011
- Meeting date: September 8-10, 2011
- Location: San Francisco, California
Visit breastcasym.org for full details.